FDA considers temporary cancer drug imports from unapproved companies to ease U.S. shortage
June 01, 2023 at 14:43 PM EDT
Shortages of cisplatin and carboplatin, bedrock cancer treatments, have forced some hospitals to ration the drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|